Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26083014 | 0.92 | GAA (0.42) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL24434345 | 0.84 | GAA (0.39) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL15672479 | 0.84 | GAA (0.39) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL316777 | 0.83 | CA2 (0.47) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL26083166 | 0.83 | GAA (0.34) | GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL26083008 | 0.82 | GAA (0.41) | GAAHTTCYP2D6LMNA | |
| SCHEMBL26083009 | 0.81 | GAA (0.44) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL19937256 | 0.81 | GAA (0.36) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL23254223 | 0.81 | CA2 (0.42) | GAAHTTCHRM2CHRM1CHRM3 | |
| SCHEMBL12368549 | 0.80 | GAA (0.42) | GAAHTTCHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | GAA 4805/4885HTT 1040/4885CHRM2 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.